Prelude Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$527K Buy
18,328
+5,369
+41% +$154K 0.05% 425
2025
Q1
$435K Buy
+12,959
New +$435K 0.03% 487